D-0633-2022 Class I Terminated
FDA drug recall D-0633-2022 was initiated by STAQ Pharma, Inc. on Feb 3, 2022 and is designated Class I. Reason for recall: Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A The recall status is terminated (terminated Sep 16, 2022). Affected quantity: 905 Syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 23, 2022
- Initiation Date
- Feb 3, 2022
- Termination Date
- Sep 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 905 Syringes
Product description
HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.
Reason for recall
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Distribution pattern
CO, OH, and TX.
Code information
Lot Number: 21104221A, Expiration date: 05-22-2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0633-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026